Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

Fred Hutch oncologists found evidence of a tumor overlooked by others that extended from the base of the skull to the ear and ...

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment ...

When it came to the study’s secondary endpoints of survival, Telix pointed to a median overall survival (OS) rate of 12.4 ...

Sabrina Lewandowski woke up one morning 23 years ago with a headache that should have killed her. The cause was a stage four ...

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment has proven effective at eliminating a hard-to-treat cancer with the only side ...

Jason Carter, grandson of former President Jimmy Carter, says he will not seek office in 2026 due to his wife Kate's ...

Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy.

Rebecca Ten Broeck of Brick has battled surgery, nausea and hair loss. But has that stopped her from pursuing her teaching degree? Certainly not.

Telix Pharmaceuticals Limited (NASDAQ:TLX) on Tuesday released preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in recurrent high-grade glioma (brain cancer ...